You are here

Home » News

Press Releases from AlphaMed Press

October 8, 2018
Stem Cells’ Consumption of ‘Sweets’ Helps Them Fight Inflammation

DURHAM, N.C. (PRWEB) OCTOBER 08, 2018

A new study published in STEM CELLS Translational Medicine shows that the energy metabolism of human mesenchymal stem cells (hMSCs) can be targeted to increase their ability to enhance tissue regeneration. The study offers a strategy that has immediate translational potential for improving hMSCs’ therapeutic success.

hMSCs have gained significant interest as an “off-the-shelf” product for cell therapy in various types of diseases. Recent findings suggest that instead of replacing damaged cells through differentiation, as initially thought, hMSCs promote tissue regeneration by coordinating multiple components of the host immune system via the release of immunomodulatory factors. Therefore, understanding the mechanism underpinning hMSC immune polarization and secretory function is critical to enhancing their therapeutic outcome.

September 24, 2018
Study Reveals Protein Behind RDEB’s Painful Symptoms and How Stem Cells Might Stop It

DURHAM, NC — A study recently published in STEM CELLS suggests unrestricted somatic stem cells (USSCs) derived from human cord blood can ease fibrosis and inflammation in a painful type of skin disorder called recessive dystrophic epidermolysis bullosa (RDEB). The stems cells also can potentially prevent malignant tumors, a frequent side effect of RDEB, from forming.

September 10, 2018
Study Shows Stem Cells May Help Restore Eyesight after a serious Chemical Burn

Durham, NC, September (2018) – A new study published in STEM CELLS Translational Medicine details a novel stem cell treatment with the potential to restore sight after a serious chemical burn to the eye.

September 5, 2018
Scaffolds Seeded With Molecule-Releasing Stem Cells Shows Promise In Treating Fatal Bone Disease

DURHAM, N.C. (SEPTEMBER, 2018)

A team of researchers developed a biocompatible scaffold seeded with molecule-releasing stem cells that, when implanted in mice with a rare but deadly bone disease called autosomal recessive osteopetrosis (ARO), showed potential to help these animals. The findings, recently published in STEM CELLS Translational Medicine (SCTM), might someday yield a treatment for humans afflicted by the same devastating condition.

August 29, 2018
Long-Term Study Shows Endothelial Progenitor Cells Are Safe for Treating Stroke Patients

DURHAM, N.C. August, 2018

A new study recently published in STEM CELLS Translational Medicine demonstrates the long-term safety of laboratory-expanded endothelial progenitor cells for treating ischemic stroke. This could be good news for the 15 million people who, according to to the World Stroke Organization, suffer from this dangerous condition each year.

August 8, 2018
Study Shows the Promise of Mesenchymal Stem Cells in Sepsis Therapy

DURHAM, N.C. AUGUST, 2018

A new study published in STEM CELLS, conducted by researchers at the University of Amsterdam, shows how mesenchymal stem cells (MSCs) have multiple immune modulatory properties that could benefit the treatment of sepsis. This study also examines the importance of how MSCs affect inflammatory responses in humans.

Sepsis is a complication caused by the body's overwhelming response to infection and can lead to organ failure. It is a major cause of morbidity and mortality worldwide. Despite the use of antibiotics and well-quipped intensive care facilities, sepsis kills about one in every four patients who contract it.

August 6, 2018
Large Scale Generation of Light-Responsive Human Retinal Organoids

 

DURHAM, N.C. AUGUST, 2018

In a new study published by STEM CELLS, researchers at Newcastle University, UK, describe a new organoid model that encompasses all human retinal cell types and that is responsive to light. Their work could have great impact on finding new treatments for the visually impaired by making drug and toxicology screening faster and more efficient.

Majlinda Lako, PhD Photo
July 30, 2018
Boosting Stem Cells With Growth Factor May Help in Treating Critical Limb Ischemia in Hemodialysis Patients

 

DURHAM, N.C. JULY 2018

A new type of stem cell treatment is showing promise for patients undergoing hemodialysis (HD) who suffer from critical limb ischemia (CLI). Results of a clinical trial, reported on in a recently published article in STEM CELLS Translational Medicine, show that five out of the six patients in the trial were CLI-free one year after treatment.

Dr. Takayasu Ohtake and Dr. Shuzo Kobayashi
July 23, 2018
Study Shows how Stem Cell Injections Helped Dogs suffering from Osteoarthritis

Durham, NC. - July 2018

Researchers have developed what appears to be a simple, minimally invasive, effective way to treat osteoarthritis (OA) in dogs that may prove to be of considerable importance in treating humans, too. The study detailing this new approach appears in the latest issue of STEM CELLS Translational Medicine (SCTM).

Dr. Offer Zeira
July 3, 2018
Enhancing Stem Cells With Oxygen and Forming Them Into Spheroids Leads to Better Bone Repair

 

DURHAM, N.C. JULY, 2018

Depriving stem cells of oxygen and forming them into spheroids before using them to treat bone defects increases their ability to form new bone and repair existing bone, according to a new study in STEM CELLS.

Pages